Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Genitourinary 7Thoracic 3Other hematologic neoplasm 3Head & Neck 3Gastrointestinal 3Lymphoid 2CNS 2Breast 2NET 1Endocrine 1Dermatologic 1

Conditions

Leukemia, Myeloid, Acute 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Brain Neoplasms 1

Interventions

venetoclax 47Cyclophosphamide 43Specimen Handling 42Cytarabine 41fludarabine 32Biopsy 31Azacitidine 25Rituximab 20Methotrexate 17fludarabine phosphate 16blinatumomab 16Vincristine 15Daunorubicin 15Dexamethasone 14ibrutinib 13Whole-Body Irradiation 13Prednisone 13Magnetic Resonance Spectroscopy 13Injections 13obinutuzumab 11merphos 11Mercaptopurine 11Filgrastim 11Calcium Dobesilate 11asciminib 10X-Rays 10Stem Cell Transplantation 10Mycophenolic Acid 10Doxorubicin 10decitabine and cedazuridine drug combination 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Watchful Waiting × Other hematologic neoplasm × 30 days × Clear all
NCT05375617 2026-06-02

EPICkids

Columbia University

Recruiting
1,400 enrolled
CNSLymphoidOther hematologic neoplasm

Brain Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07613385 2026-05-29

Individualized AML Treatment

City of Hope Medical Center

Recruiting
18 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02275533 2026-05-28

Testing Nivolumab to Prevent Disease From Coming Back After Treatment in Patients With Acute Myeloid Leukemia, REMAIN Trial

National Cancer Institute (NCI)

Phase 2 Active not recruiting
82 enrolled 13 charts
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡